Prostate Cancer

Protocol #SponsorProtocol Title
NCT0112004

EMD Serono
EMR 100070-001, 2013-002834-19
A Phase I, Open-Label, Multiple-Ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of Avelumab (MSB0010718C) in Subjects with Metastatic or Locally Advanced Solid Tumors and Expansion to Selected Indications (JAVELIN)

Northwest Georgia Oncology Centers‘ (NGOC) physicians work with urologists to provide expert care to patients with prostate cancer.